Sorafenib

Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:Sorafenib
CAS No.:475207-59-1
Standard:In-house Standards
Price(USD):0.00
Company:Viwit Pharmaceutical Co., LTD

Basic Info
  • Grade: Pharmaceutical Grade

    Factory Location: Shandong

    Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa

  • Sample Provided: no

     

    Sorafenib Tosylate with CAS 475207-59-1 is co-developed and co-marketed by Bayer and Onyx Pharmaceuticals as Nexavar.

     

    Sorafenib Tosylate (CAS 475207-59-1) is approved in the US for the treatment of primary kidney cancer (advanced renal cell carcinoma), advanced primary liver cancer (hepatocellular carcinoma), and radioactive iodine resistant advanced thyroid carcinoma.

    The product above are not for sales where the patents are applicable and still valid.

Send your message to this supplier
  • From:
  • To:
    Viwit Pharmaceutical Co., LTD
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service